CRISPR Therapeutics AG

CRSP · NASDAQ

$49.88−$0.16 (−0.32%)TodayMarket closed ·
Prev close $50.04

Who owns CRSP

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 44.7% of CRSP’s shares.

  • ARK Investment Management LLC9.8%
  • BlackRock Institutional Trust Company, N.A.7.6%
  • Orbis Investment Management Ltd.5.6%
  • Capital World Investors4.9%
  • Next 6 largest institutions16.8%
  • All other shareholders55.3%
Top institutional holders of CRSP
HolderShares% of shares
ARK Investment Management LLC9.46M9.81%
BlackRock Institutional Trust Company, N.A.7.30M7.57%
Orbis Investment Management Ltd.5.45M5.65%
Capital World Investors4.75M4.92%
State Street Investment Management (US)4.32M4.48%
GSK plc3.22M3.34%
Geode Capital Management, L.L.C.2.51M2.60%
T. Rowe Price Investment Management, Inc.2.05M2.13%
George (Simeon J.)2.04M2.11%
SR One Capital Management, LP2.04M2.11%

Largest mutual fund holders

Top mutual fund holders of CRSP
HolderShares% of shares
ARK Innovation ETF5.25M5.45%
iShares Russell 2000 ETF2.39M2.48%
ARK Genomic Revolution ETF2.16M2.24%
State Street SPDR S&P Biotech ETF2.12M2.20%
American Funds New Perspective Fund1.94M2.02%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $2.71M (7 trades) of CRSP on the open market, with no buys.

Latest CRSP insider transactions
InsiderTypeSharesValue
George SimeonOption exercise30.00K—
George SimeonSale14.51K$720.37K
George SimeonOption exercise30.00K$420.00K
KASINGER JAMES R.Sale1.04K$51.23K
Kulkarni SamarthSale4.10K$201.87K
KASINGER JAMES R.Option exercise2.11K—
KASINGER JAMES R.Option exercise2.11K—
Kulkarni SamarthOption exercise8.33K—
Kulkarni SamarthOption exercise8.33K—
KASINGER JAMES R.Option exercise1.99K—

Short interest

Settled Sep 30, 2026

Shares short
18.68M
Days to cover
9.58
% of shares outstanding
19.37%
Average daily volume
1.95M
Change since last report
−2.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.